Funding for Domestic HIV Programs Sustained, Promise of HIV Research and PEPFAR Stagnated in President’s Budget

HIVMA Recommends Doctors, Patients Discuss Need for Common Tests

House Committee on Oversight and Government Reform’s Hearing on Developments in the Prescription Drug Market

Update to the National Viral Hepatitis Action Plan

Testimony for the Record to the House Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies Regarding Fiscal Year 2020 Appropriations for Federal HIV and Related Programs

Our members provide medical care and treatment to people living with HIV in the U.S. and globally, lead HIV prevention programs and conduct research that has led to the development of effective HIV prevention and treatment options

IDSA, HIVMA & PIDS Members Call on Candidates to Address ID Threats

More than 500 physicians, health care providers and researchers urge Presidential candidates to prioritize ID and HIV responses.

Act Now to Protect Non-Discrimination Protections Under ACA Section 1557

HHS is proposing to significantly narrow the ACA’s non-discrimination protections. Take action to urge protections for LGBTQ people and patients with HIV are maintained.

IDSA Congratulates 23 Institutions on Centers of Excellence Designation

IDSA has awarded 23 institutions the designation of Antimicrobial Stewardship Centers of Excellence (CoE).

Capped Medicaid Funding Threatens Federal HIV Goals and Broader Public Health

Giving states a new option to impose new restrictions on some program beneficiaries would represent a setback to essential health service access, and add a new challenge to the Ending the HIV Epidemic initiative.

IDSA and HIVMA Respond to Administration Guidelines to Control COVID-19 Spread

The Infectious Diseases Society of America and its HIV Medicine Association endorse the measures to control the spread of COVID-19 called for by the Trump administration Monday.

IDSA and HIVMA Applaud Selection of Dr. Rochelle Walensky to Lead CDC

The Infectious Diseases Society of America and its HIV Medicine Association welcome President-elect Biden’s selection of Dr. Rochelle Walensky to lead the U.S. Centers for Disease Control and Prevention.

Statement on Resignation of NIH Director Francis Collins

Dr. Collins has provided a steady, scientific voice throughout the COVID-19 pandemic. Under his leadership, NIH was instrumental in researching, developing and communicating about lifesaving COVID-19 vaccines and treatments.